NBT Bank’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
IA
VCM
VAM
NBT Bank's AZN Position: Q1 2026 in Review
NBT Bank sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 157 shares — an estimated $28.8K sold.
NBT Bank first reported a position in AZN in Q3 2024 and held it in 6 quarters. The position peaked at $71.1K in Q3 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- NBT Bank reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- NBT Bank sold 157 AstraZeneca shares in Q1 2026, an estimated $28.8K.
- NBT Bank first reported a position in AstraZeneca in Q3 2024 and held it in 6 quarters.
- NBT Bank's AstraZeneca position peaked at $71.1K in Q3 2024.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.